AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update
Population
Patients with atherosclerotic cardiovascular disease
Design
Guideline
Authors
Discussion
Loading...
Member takes
Implication
Supports aggressive risk factor management in secondary prevention; extends 1995 guidelines with new trial evidence.
Key Points
- To update the 1995 AHA/ACC consensus recommendations for secondary prevention of cardiovascular events in patients with established atherosclerotic cardiovascular disease.
- Review and synthesis of emerging evidence from clinical trials on secondary prevention published since the 1995 guidelines.
- Assessment of aggressive therapeutic strategies targeting cardiovascular risk factor reduction.
- Aggressive risk factor management substantially increases overall patient survival and decreases the recurrence of cardiovascular events.
- Intensive risk reduction therapies lower the frequency of required interventional procedures and enhance patient quality of life.
Structured PICO
P
Population
Patients with atherosclerotic cardiovascular disease
I
Intervention
Aggressive risk reduction therapies (risk factor management)
The 2001 AHA/ACC guideline update reinforces the importance of aggressive risk reduction therapies for secondary prevention in patients with atherosclerotic cardiovascular disease.
Cite This Study
Smith et al. (2001) studied this question.